Radcliffe Capital Management’s Sanaby Health Acquisition Corp. I Class A Common Stock SANB Stock Holding History

Radcliffe Capital Management’s Portfolio SANB Stock Details SANB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-60,701	Closed	-$615K	–	1181
2022 Q3	$615K	Hold	60,701	–	–	0.01%	1036
2022 Q2	$609K	Buy	60,701 +4,400	+8%	+$44.2K	0.01%	1090
2022 Q1	$563K	Buy	56,301 +36,301	+182%	+$362K	0.01%	1101
2021 Q4	$199K	Buy	+20,000	New	+$199K	0.01%	1026

Radcliffe Capital Management's SANB Position: Q4 2022 in Review

Radcliffe Capital Management sold out of Sanaby Health Acquisition Corp. I Class A Common Stock (SANB) in Q4 2022, closing a stake of 60,701 shares — an estimated $615K sold.

Radcliffe Capital Management first reported a position in SANB in Q4 2021 and held it in 4 quarters. The position peaked at $615K in Q3 2022. 0 funds tracked by Wall St. Rank hold SANB as of Q4 2022.

Radcliffe Capital Management reported no remaining Sanaby Health Acquisition Corp. I Class A Common Stock position as of Q4 2022 after selling out during the quarter.
Radcliffe Capital Management sold 60,701 Sanaby Health Acquisition Corp. I Class A Common Stock shares in Q4 2022, an estimated $615K.
Radcliffe Capital Management first reported a position in Sanaby Health Acquisition Corp. I Class A Common Stock in Q4 2021 and held it in 4 quarters.
Radcliffe Capital Management's Sanaby Health Acquisition Corp. I Class A Common Stock position peaked at $615K in Q3 2022.
0 funds tracked by Wall St. Rank held Sanaby Health Acquisition Corp. I Class A Common Stock as of Q4 2022.

Based on Radcliffe Capital Management's 13F filing for Q4 2022, filed 14 Feb 2023.